{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:12:11Z","timestamp":1775027531662,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.drugalcdep.2007.03.010","type":"journal-article","created":{"date-parts":[[2007,5,11]],"date-time":"2007-05-11T07:47:15Z","timestamp":1178869635000},"page":"292-296","source":"Crossref","is-referenced-by-count":38,"title":["Implementation of buprenorphine in the Veterans Health Administration: Results of the first 3 years"],"prefix":"10.1016","volume":"90","author":[{"given":"Adam J.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodie A.","family":"Trafton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen L.","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent S.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"McNicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Liberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2007.03.010_bib1","unstructured":"Addiction Management Systems, 2006. Addiction management systems. Available from: http:\/\/www.addictionmanagement.com\/Benefits.htm. Accessed on: December 5, 2006."},{"key":"10.1016\/j.drugalcdep.2007.03.010_bib2","unstructured":"Dalton A., Saweikis M., McKellar J.D., 2006. Health services for VA substance use disorder patients. Comparison of utilization in fiscal years 2005, 2004, 2003, and 2002. Available from: http:\/\/www.chce.research.med.va.gov\/pdf\/2005Yellowbook.pdf. Accessed on: December 6, 2006."},{"issue":"11","key":"10.1016\/j.drugalcdep.2007.03.010_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMcp013579","article-title":"Office-based treatment of opioid dependent patients","volume":"347","author":"Fiellin","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.drugalcdep.2007.03.010_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.drugalcdep.2007.03.010_bib5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1176\/appi.ajp.158.8.1200","article-title":"Office-based treatment for opioid dependence: reaching new patient populations","volume":"158","author":"Fiellin","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.drugalcdep.2007.03.010_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2007.03.010_bib7","unstructured":"Goodman F., Gordon A., Kivlahan D., Dalack G., Pope J., McNicholas L., Suchinsky R. for the VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel. Criteria for non-formulary use of Buprenophine Sublingual tablets for Opioid Dependence, Criteria for Use Monograph. 2003."},{"issue":"3","key":"10.1016\/j.drugalcdep.2007.03.010_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinte.164.3.277","article-title":"Treating opioid dependence. Growing implications for primary care","volume":"164","author":"Krantz","year":"2004","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.drugalcdep.2007.03.010_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.drugalcdep.2007.03.010_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","article-title":"The efficacy of methadone maintenance interventions in reducing illicit opiate use. HIV risk behavior and criminality: a meta-analysis","volume":"93","author":"Marsch","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2007.03.010_bib11","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2","author":"Mattick","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2007.03.010_bib12","series-title":"Health Services For VA Substance Use Disorder Patients: Comparison of Utilization in Fiscal Years 2004, 2003 And 1998","author":"McKellar","year":"2005"},{"issue":"1","key":"10.1016\/j.drugalcdep.2007.03.010_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-133-1-200007040-00008","article-title":"Pharmacologic treatment of heroin-dependent patients","volume":"133","author":"O\u2019Connor","year":"2000","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.drugalcdep.2007.03.010_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1345\/aph.10421","article-title":"Opioid dependence treatment, including buprenorphine\/naloxone","volume":"36","author":"Raisch","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2007.03.010_bib15","unstructured":"Stanton A., McLeod C., Luckey B., Kissin W.B., Sonnefeld L.J., 2006. SAMHSA\/CSAT evaluation of the buprenorphine waiver program. Expanding treatment of opioid dependence: initial physician and patient experiences with the adoption of buprenorphine. Available from: http:\/\/buprenorphine.samhsa.gov\/ASAM_06_Final_Results.pdf. Accessed on: December 5, 2006."},{"issue":"11","key":"10.1016\/j.drugalcdep.2007.03.010_bib16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2007.03.010_bib17","series-title":"Glossary of Terms Used in the Federal Budget Process","author":"United States Government Accountability Office","year":"2005"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871607001500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871607001500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T13:50:43Z","timestamp":1546869043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871607001500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":17,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0376871607001500"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.03.010","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}